Menu

Tiny Tunnels Run from the Skull to the Brain: Study

Immune cells travel through these passageways to get to injured tissue quickly, researchers say.

Aug 29, 2018
Ashley Yeager

ABOVE: Newly discovered channels between the skull and the brain
NAHRENDORF LAB

Never-before-seen microscopic tunnels connect the bone marrow in the skull to the lining of the brain called the meninges, researchers reported Monday (August 27) in Nature Neuroscience. The finding could offer insights to how the brain responds to injury and disease.

“We always thought that immune cells from our arms and legs traveled via blood to damaged brain tissue. These findings suggest that immune cells may instead be taking a shortcut to rapidly arrive at areas of inflammation,” Francesca Bosetti, program director at the US National Institute of Neurological Disorders and Stroke, which funded the study, says in a statement. “Inflammation plays a critical role in many brain disorders and it is possible that the newly described channels may be important in a number of conditions.”

Matthias Nahrendorf, a molecular biologist at Harvard Medical School and Massachusetts General Hospital in Boston (MGH), and his colleagues discovered the channels while trying to determine where immune cells come from after a stroke or heart attack. In mice having a stroke, immune cells called neutrophils are more likely to come from the skull, they found. But in mice that have had a heart attack, a similar number of neutrophils come from the skull and the tibia. 

In the case of stroke, advanced imaging showed the neutrophils leaving the skull and traveling through the previously undiscovered tunnels to the damaged tissue. An analysis of human skull samples after surgery revealed the channels are not unique to mice.

“While we’ve still got a lot to learn about these channels, I think their very special role as conduits for inflammatory cross-talk between the marrow and the central nervous system is quite different from any other vasculature,” Nahrendorf says in an MGH statement. “In addition to these channels carrying immune cells from the skull marrow to the brain, we think inflammatory substances that derive from the brain may alert the skull marrow to an injury faster than marrow from the rest of the body.”

Because inflammation is part of many brain diseases, “it would be great to learn how the channels contribute to those diseases and whether modulating their contributions could change outcomes,” Nahrendorf says. “Another idea is that the channels could serve as a route of drug delivery, allowing transport to the meninges of drugs delivered into the skull marrow.”

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.
Corning Introduces New 1536-well Spheroid Microplate
Corning Introduces New 1536-well Spheroid Microplate
High-throughput spheroid microplate benefits cancer research, drug screening